Review article: Pathogenesis and management of gastric carcinoid tumours.
about
Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisalMetabolic Functions of the Lung, Disorders and Associated PathologiesAutoimmune atrophic gastritis: current perspectives.Endoscopic ultrasonography for gastric submucosal lesions.Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.A case of metastatic gastric neuroendocrine tumor: therapeutic considerations.Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.Comparison of the clinical value of multi-band mucosectomy versus endoscopic mucosal resection for the treatment of patients with early-stage esophageal cancer.Type I gastric carcinoids in atrophic gastritisCancer Risk After Pernicious Anemia in the US Elderly Population.Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors.Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor.Differing Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme.Gastric carcinoids: between underestimation and overtreatment.Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjectsNetazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects.Long-term follow up of endoscopic resection for type 3 gastric NET.Gastric carcinoid tumor in a patient with a past history of gastrointestinal stromal tumor of the stomach.A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.Gastric polyps: a review of clinical, endoscopic, and histopathologic features and management decisions.Autoimmune gastritis: histology phenotype and OLGA staging.Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells.Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.A case of mixed adenoneuroendocrine carcinoma of the stomach with focal intestinal metaplasia and hypergastrinemia.Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist.Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1.Importance of gastrin in the pathogenesis and treatment of gastric tumors.Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate.Updated features associated with type 1 gastric carcinoids patients: a single-center study.Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.GASTRIC NEUROENDOCRINE TUMOR: REVIEW AND UPDATE.Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.Epigenetic regulation by the menin pathway.Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
P2860
Q27021198-0627906B-6485-4CC9-B721-11A767922489Q28072037-AE1E142B-7012-4FD9-8B70-0262186A57C0Q30235618-A475E610-03F6-4653-B0BB-FB2A06A71221Q30474793-B3397FAB-8266-4A0A-A460-FFED18E12A02Q31095566-7DDED2F1-927C-4E6F-8211-084E2159B862Q33628260-368B857C-69C4-41AB-9401-A476BA185444Q35009459-943CB194-3CA1-444B-B505-5992D852B515Q35557414-16327F63-07A2-4262-8881-E0D383B1030BQ35758467-111596B7-C968-4301-995B-673511B7E212Q35977898-F99CFAA4-9A8E-40D0-881B-7A07C0C5E7F0Q36304871-7C1DABA5-4439-4B27-9015-1597A5E87E9BQ36385139-AF448EC2-BFBB-4307-AC98-DBFB511CC831Q36956089-43E88409-82A1-48E7-87D2-9AE981D925CDQ37026099-98AB491A-55F0-42D8-97DD-037EB851AD6EQ37192619-54E7351F-3BB8-4F1A-BF4F-D2F65F2845CAQ37369296-430E4E4B-AC8C-4010-A074-86D38EFDFF6CQ37369301-47CF9BCB-233C-4E88-989C-5BB0E41ED5E9Q37408875-05E18A76-EE96-4943-BBB1-FB555096C22BQ37413303-B21719BB-1B69-4ED2-825E-41CA68B9D6CDQ37520436-C9A90158-1215-48B6-9F7A-1429429172F0Q37710788-029F9319-8742-41D7-9333-FCB5D8A8286CQ38004059-96CC4522-7C8E-4F05-B71F-EFF81AAF4747Q38205916-2A78DD85-581E-4C00-831D-280146A2BB5EQ38470380-5BDB959F-A077-48FA-90C3-0DA9A3051FE1Q38795398-E505D743-DA8E-4F58-885B-166A1ADA523BQ39669592-570454F4-659C-4369-831E-8C46B6139A6EQ40699250-7BFEF45E-A98F-4DCD-B20F-72ED30F4F183Q41152322-4453417B-CE97-4550-94E2-E69CC1D59FA9Q41416234-7BDFE072-3083-40AE-BB8F-ECEBADB15A0DQ41458940-7C0CAC4D-5346-49FF-AEAC-FC6D83A9B6D9Q42424883-282E5A91-B543-4E8A-B4AC-B44F0C83EE45Q43166070-F9B4DAD8-6A36-4D58-87AF-2729351459E8Q44309891-BD9C38BF-526D-4DFC-BDA8-9EC93C07BF40Q45163316-4A601EDF-EA95-4839-A5D2-27B9104EB1C8Q46270157-6B51EA21-6F9B-4286-B9D7-787713D363A5Q47116429-EEFE0F51-342C-4E30-A0C5-A0E9DE01712BQ47125238-63CE01DA-B8E6-4367-9239-081D3A1EDD8DQ47200269-C5240608-15FC-4455-8115-AE4CE1BB3CA4Q47948643-42900F3D-FC89-4778-ABF9-A4E20FCA65C1Q48009649-76F60553-3464-4B16-BCE4-03FC7AC92C96
P2860
Review article: Pathogenesis and management of gastric carcinoid tumours.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Review article: Pathogenesis and management of gastric carcinoid tumours.
@ast
Review article: Pathogenesis and management of gastric carcinoid tumours.
@en
type
label
Review article: Pathogenesis and management of gastric carcinoid tumours.
@ast
Review article: Pathogenesis and management of gastric carcinoid tumours.
@en
prefLabel
Review article: Pathogenesis and management of gastric carcinoid tumours.
@ast
Review article: Pathogenesis and management of gastric carcinoid tumours.
@en
P2860
P1476
Review article: Pathogenesis and management of gastric carcinoid tumours
@en
P2093
Burkitt MD
Pritchard DM
P2860
P304
P356
10.1111/J.1365-2036.2006.03130.X
P407
P577
2006-11-01T00:00:00Z